C11977: Neonatal Hypothermic Therapy for Developing CountriesNovelty:
A device and method for providing hypothermic therapy without using electricity.
Value Proposition:
Hypoxic ischemia-encephalopathy (HIE) is a life threatening condition in which there is a lack of oxygen to the brain. It occurs in 5 of every 1000 births of which 10-60% result in death, while 25% of survivors are left disabled. Furthermore, asphyxia accounts 23% of newborn deaths each year. Both of these conditions can be treated with hypothermic therapies, where the body and brain are cooled to slow metabolic rates. However, these techniques are not currently available to developing nations, due to the cost and need for electricity. This invention provides an inexpensive method to apply ideal therapeutic conditions. Other advantages to this invention are:
• Easy to construct and operate.
• Uses readily-available materials.
• Inexpensive to construct.
• Lightweight and portable
Technical Details:
Johns Hopkins researchers have developed a system that can be used to treat HIE and asphyxia in neonates in developing countries. The device is able to rapidly and effectively cool core temperature to desired levels for applying such therapies. This is accomplished without the need to be connected to an electrical grid or generator. Materials can be locally sourced in many regions, are reusable, and are expected to cost no more than $40.
Looking for Partners:
To develop & commercialize the technology as a body cooling device in the Patient Temperature Management Market in developing nations.
Stage of Development:
Prototype
Data Availability:
Cooling effectiveness alone and with a piglet
Publications/Associated Cases:
Not at this time
Patent Information:
| Title |
App Type |
Country |
Serial No. |
Patent No. |
File Date |
Issued Date |
Expire Date |
Patent Status |
